Adaptive Biotechnologies Stock Quote ADPT - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

4.06

Bid

3.96

Ask

4.06

Volume

872,066

3.981 Day's Range 4.17

2.28 52 Week Range 6.34

Market Cap

598.737M

Previous Close

4.17

Open

4.17

Last Trade

100

4.06

(formt)

Last Trade Time

Financial Volume

$ 3,526,943

VWAP

4.0444

Average Volume (3m)

1,162,780

Shares Outstanding

147,472,201

Dividend Yield

PE Ratio

-2.63

Earnings Per Share (EPS)

-1.53

Revenue

170.28M

Net Profit

-225.25M

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.adaptivebiotech.com

Headquarters

Olympia, Washington, USA

Founded

Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $4.17. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 2.28 to $ 6.34.

Adaptive Biotechnologies currently has 147,472,201 shares outstanding. The market capitalization of Adaptive Biotechnologies is $614.96 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -2.63.

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.58	-12.5	4.64	4.98	3.9	812645	4.53204469	CS
4	-0.57	-12.3110151188	4.63	4.98	3.9	793946	4.47181409	CS
12	0.68	20.1183431953	3.38	5.04	3.3	1162780	4.3765633	CS
26	0.82	25.3086419753	3.24	5.04	2.28	1446299	3.58352686	CS
52	-0.93	-18.6372745491	4.99	6.34	2.28	1478064	3.96009878	CS
156	-32.02	-88.7472283814	36.08	37.55	2.28	1246509	8.20209081	CS
260	-33.69	-89.2450331126	37.75	71.25	2.28	1112005	18.4738546	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RZLVRezolve AI Ltd	$ 7.44 (51.22%)	3.17M
RNAZTransCode Therapeutics Inc	$ 0.63 (51.12%)	12.73M
ATGLAlpha Technology Group Limited	$ 2.16 (49.72%)	3.42M
INVZWInnoviz Technologies Ltd	$ 0.18 (45.69%)	11.02k
OCTOEightco Holdings Inc	$ 3.61 (44.98%)	100.6M
VTNRVertex Energy Inc	$ 0.1501 (-58.42%)	49.72M
CMCTCreative Media and Community Trust Corporation	$ 0.71 (-54.63%)	3.56M
SFIXStitch Fix Inc	$ 2.28 (-39.20%)	23.88M
SHOTWSafety Shot Inc	$ 0.22 (-31.25%)	11.82k
ARQQArqit Quantum Inc	$ 4.40 (-29.63%)	438.63k
NVDANVIDIA Corporation	$ 123.51 (2.18%)	284.47M
MLGOMicroAlgo Inc	$ 0.2744 (26.92%)	142.29M
SQQQProShares UltraPro Short QQQ	$ 7.47 (-2.35%)	124.09M
CEROCERo Therapeutics Holdings Inc	$ 0.0986 (5.23%)	123.58M
INTCIntel Corporation	$ 23.54 (3.20%)	117.01M